On August 23, the 23rd Edition of Pet Asia was successfully closed at the Shanghai New International Expo Centre. Compared with previous exhibitions, although this year's Asian pet exhibition is the first large-scale exhibition of the pet industry under the epidemic, the scale has been upgraded again, and the number of exhibitors has exceeded 2,000, which also confirms the growth of the pet industry against the trend under the baptism of the epidemic. At the exhibition site where brands gather, Remigao not only shines with diversified products, but also wins a number of industry awards, which also means the further implementation of Remigao's "pet food + pet medicine two-wheel drive" strategy.
The core strategy of the development of "pet food + pet medicine" two-wheel drive is the strategic goal launched by Remigao in 2018. In order to promote the implementation of the goal, Remigao has built four major brands in the pet food sector, namely Oride (value-added national pet food), Aobao (Aobao classic hero dog food, Aobao vitality fruit nutrition double spelling), Saiji (ideal body race grade formula) and vitality Thai (functional formula) to meet consumers' demand for diversified pet food.
As the focus of the company's strategic goals, as early as June this year, vitality Thai functional food as early as June this year through the sponsorship of Jiangsu Satellite TV "Sunshine Sister Tao" reality show, enhance the brand awareness and reputation, and the new products of the nutritional paste series unveiled at the Asian Pet Exhibition site are also the main products of Vitality Thai, which not only adds active herbal extracts, which can more effectively help pets solve health problems and enhance pet immunity, but also uses the form of concentrated paste to ensure the comprehensive absorption of nutrition.
In the pet medicine sector, Remigao has built a perfect anthelmintic drug product matrix, including in vivo and foreign deworming drugs, topical local inflammatory drugs (eyes, ears, skin), internal gastrointestinal andpulmonary heart drugs, biosecurity drugs (disinfection, deodorization) and other fields, and relying on the advantages of Aolong Pharmaceutical (China's top 30 veterinary drug preparation enterprises) to ensure the safety and stability of products, becoming the preferred brand in domestic cost-effective pet drug products.
At the same time, in order to meet the needs of the company's development and transformation and upgrading, and further enhance the production and supply capacity of products, Remigao also spent 150 million yuan to build a modern veterinary drug production base with an annual output of 20,000 tons, and adopted a process design that meets the requirements of the latest version of GMP of the Ministry of Agriculture and the production equipment of the cold storage air conditioning system and automation, and the base was officially put into operation this year and became one of the most modern veterinary drug preparation production bases in South China.
Talking about the company's competitive advantage with foreign manufacturers in the category of insect repellent drugs, Zou Liansheng, executive director of Remigao, said: "Although foreign manufacturers have a longer period of precipitation in this field, and the brand influence is higher, as a domestic brand, we are actually not inferior to foreign manufacturers in terms of production and manufacturing level, product stability and quality, etc. In the future, the company will continue to invest in brand marketing, so that more pet users can understand and experience Remigao's products - easy to use and not expensive." ”
The two-wheel drive development strategy of "pet food + pet medicine" is an important step for Remigao to build and improve the supply chain system and achieve global development. In the future, Remigao will continue to gain insight into consumer needs, continue to develop new products, pass on better ideas and products to consumers, and provide pets with more diversified and personalized products and services.